
|Articles|May 1, 2004
FDA approval benefits presbyopic patients
Irvine, CA-The FDA approval of the ViewPoint CK System (Refractec Inc.) for the NearVision conductive keratoplasty (CK) procedure marked a milestone as the first technology to improve near vision in presbyopic patients (See related story from Ophthalmology Times, March 1 issue). The laser-free procedure-which uses radiowaves to reshape the cornea-can be performed in less than 3 minutes with topical anesthesia in the ophthalmologist's office.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























